A share price of Better Therapeutics Inc [BTTX] is currently trading at $0.22, up 11.86%. An important factor to consider is whether the stock is rising or falling in short-term value. The BTTX shares have gain 17.17% over the last week, with a monthly amount glided 26.32%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 5, March 2024, Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers. In a post published today on Yahoo Finance, One million prescriptions for AspyreRx will be offered to patients in underserved communities disproportionately affected by type 2 diabetes.
From an analyst’s perspective:
Better Therapeutics Inc [NASDAQ: BTTX] stock has seen the most recent analyst activity on November 24, 2021, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $17.
Better Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.14 and $1.61. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Better Therapeutics Inc [NASDAQ: BTTX] shares were valued at $0.22 at the most recent close of the market. An investor can expect a potential return of 7627.27% based on the average BTTX price forecast.
Analyzing the BTTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.94, Equity is 4.01 and Total Capital is 13.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1968 points at the first support level, and at 0.1786 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2266, and for the 2nd resistance point, it is at 0.2382.
Better Therapeutics Inc [BTTX] reported earnings per share of -$0.15 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.19/share, meaning a difference of $0.04 and a surprise factor of 21.10%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.24 per share as compared to estimates of -$0.31 per share, a difference of $0.07 representing a surprise of 22.60%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Better Therapeutics Inc [NASDAQ:BTTX] is 0.57. On the other hand, the Quick Ratio is 0.57, and the Cash Ratio is 0.51.
Transactions by insiders
Recent insider trading involved PERRY DAVID P, Executive Chairman, that happened on Jul 27 ’23 when 1.23 million shares were purchased. Director, Parker Geoffrey M. completed a deal on Jul 27 ’23 to buy 0.69 million shares. Meanwhile, Director Armanino Andrew J. bought 0.27 million shares on Jul 27 ’23.
